mepenzolate has been researched along with Centriacinar Emphysema in 2 studies
mepenzolic acid: anticholinergic, antispasmodic agent; RN given refers to parent cpd; structure
| Excerpt | Relevance | Reference |
|---|---|---|
| "The clinical treatment of chronic obstructive pulmonary disease (COPD) requires not only an improvement of airflow by bronchodilation but also the suppression of emphysema by controlling inflammation." | 1.39 | Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease. ( Iijima, K; Ishihara, T; Kobayashi, D; Mizushima, T; Mogushi, K; Sato, K; Sugizaki, T; Suzuki, H; Tahara, K; Tanaka, H; Tanaka, K; Yamakawa, N; Yamashita, Y, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamashita, Y | 2 |
| Tanaka, KI | 1 |
| Yamakawa, N | 2 |
| Asano, T | 1 |
| Kanda, Y | 1 |
| Takafuji, A | 1 |
| Kawahara, M | 1 |
| Takenaga, M | 1 |
| Fukunishi, Y | 1 |
| Mizushima, T | 2 |
| Tanaka, K | 1 |
| Ishihara, T | 1 |
| Sugizaki, T | 1 |
| Kobayashi, D | 1 |
| Tahara, K | 1 |
| Iijima, K | 1 |
| Mogushi, K | 1 |
| Tanaka, H | 1 |
| Sato, K | 1 |
| Suzuki, H | 1 |
2 other studies available for mepenzolate and Centriacinar Emphysema
| Article | Year |
|---|---|
Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity.
Topics: Administration, Inhalation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzilates; Bronchodil | 2019 |
Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Animals; Anions; Anti-Inflammatory Agents; Benzilates; Bronchoalveolar L | 2013 |